MetGen is Finnish Biotech company founded in 2008 to provide tailor-made robust enzymatic solutions to industry. Our mission is: we are empowering industries to get most out of biomass through enzymatic solutions.

Our core competence is in enzyme engineering, application testing, and efficient and cost-effective production. We have been successful in developing and supplying a number of unique enzymatic solutions for our customers in bio-based industries. The main focus of MetGen’s activities is on BioEnergy, Renewable chemicals, and Pulp&Paper sectors.

An important part of MetGen’s activities is innovation, research, and development. MetGen is active and visible in European Union Horizon 2020 program, has numerous projects and collaboration partners in European projects alone. One of the most important achievements in the EU fund-raising is the 2018 Horizon 2020 Flagship project SWEETWOODS. For more information please click on this link

MetGen has Strong IP portfolio – five families of granted patents and over 10 families under examination.
In 2018 MetGen has opened a fungal genetics unit in Brightlands Chemelot campus to boost its offerings and production efficiency even further.